Retrospective Evaluation of a Novel Biomimetic Synthetic Bone Substitute (Creos® Syntogain)
Retrospective Data Collection Evaluating the Performance of a Novel Biomimetic Synthetic Bone Substitute (Creos® Syntogain) up to 72 Months Follow-up
1 other identifier
observational
173
1 country
2
Brief Summary
Guided bone regeneration (GBR) is a commonly performed technique, using autogenous grafts, allografts, xenografts, or synthetic bone grafts (SBG). Advantages of an "off the shelf" substitute, available anytime with limitless fabrication capacity that avoids human, or animal associated morbidity provides SBG with a very positive future perspective. This data collection is to retrospectively evaluate the long-term clinical performance of a CE marked biomimetic SBG substitute in patients with implant placement related bone regeneration treatments up to 72 months of follow-up. The study hypothesis states that a biomimetic SBG is a verified graft choice to be used clinically in patients with implant placement related bone regeneration treatments such as socket preservation with a delayed implant placement, GBR simultaneous with immediate implant placement, and sinus lift elevation with lateral approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2023
CompletedFirst Submitted
Initial submission to the registry
June 13, 2024
CompletedFirst Posted
Study publicly available on registry
June 25, 2024
CompletedJune 25, 2024
June 1, 2024
9 months
June 13, 2024
June 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Implant survival
Implant in place at any follow up visit
From final prosthesis delivery through study completion, up to 72 months.
Prosthesis survival
Prosthesis survival at any follow up visit
From final prosthesis delivery through study completion, up to 72 months.
Secondary Outcomes (3)
Complications
From initial surgical procedure date (GBR or implant placement) through study completion, up to 72 months
Peri-implant evaluation, marginal bone loss
From final prosthesis delivery through study completion, up to 72 months.
Peri-implant evaluation, soft tissue evaluation PES-WES score
From final prosthesis delivery through study completion, up to 72 months.
Study Arms (4)
Socket Preservation
Socket preservation is completed at the time of extraction. After removal of the tooth, the gum is elevated away from the bone, the socket is thoroughly cleansed, the socket is packed with the SBG and the wound closed. A healing time between 3 to 9 months is .
Immediate implant placement
Implant placement immediately after tooth extraction, the bone grafting material is packed between the implant and the bone wall.
Guided bone regeneration
When ridge augmentation is indicated, guided bone regeneration with the SBG and a barrier membrane are utilized at the time of tooth extraction or at an edentulous bone ridge. Either simultaneous implant placement or delayed implant placement are performed at the time of GBR surgery or after a 4 to 9 months healing time respectively.
Sinus elevation
Schneiderian membrane elevation to increase the residual crestal bone height in the posterior maxilla, bone grafting material is placed into the newly created space, including elevation through the lateral approach.
Eligibility Criteria
Community population attending to one of the centers adhered to the study.
You may qualify if:
- The subject was at least 18 years of age (or age of consent) and has finalized skeletal growth at the time of surgery.
- Patient was in need of one or multiple tooth replacements.
- Treatment using synthetic bone graft was done for implant placement either in IIP or DIP.
You may not qualify if:
- Previous bone augmentation procedures with a different treatment choice (lateral or vertical regeneration).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- International dentistry Research Grouplead
- Nobel Biocarecollaborator
Study Sites (2)
Clínica Dental Altes Mesquida
Palma de Mallorca, Balearic Islands, 07004, Spain
Cairó Franch Clinica Dental
Barbera Del Valles, Barcelona, 08210, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juan Mesquida, DDS
International Dentistry Research Group Clinical Director
- PRINCIPAL INVESTIGATOR
Ignacio Ginebreda, DDS
International Dentistry Research Group co-Clinical Director
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2024
First Posted
June 25, 2024
Study Start
April 1, 2023
Primary Completion
December 20, 2023
Study Completion
December 20, 2023
Last Updated
June 25, 2024
Record last verified: 2024-06